Actively Recruiting
Rehabilitation Improved by Early Detection of Fisyulas Post (Pharyngo) -Total Laryngectomy by Cytokine Measurement on Drainage Fluid on the Second Post-Operative Day
Led by University Hospital, Clermont-Ferrand · Updated on 2025-09-22
250
Participants Needed
7
Research Sites
167 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Post-pharyngo-laryngectomy fistula is a frequent surgical complication, resulting in delayed patient management and reduced quality of life. A recent study has shown that the appearance of a fistula can be detected early by measuring cytokines (particularly IL10) in postoperative drainage fluids. Resumption of feeding following this surgery varies between postoperative day 5 and postoperative day 15, depending on the team\'s habits. Early refeeding reduces the length of hospital stay and improves patients\' quality of life. The decision to refeed is currently made without any clinical or biological marker of the quality of pharyngeal suture healing. The idea of this study is that good initial healing (evidenced by low levels of inflammatory cytokine in drainage fluids) allows early refeeding without putting the patient at additional risk. Main hypothesis and research objectives Main hypothesis: the determination of cytokines in postoperative drainage fluids (FODP) could be a tool for screening patients at no risk of developing a fistula, and for whom early refeeding (as early as postoperative day 3) could be proposed without exposing the patient to an additional risk of developing a FODP. Study objectives Primary objective: to compare the rate of post-(pharyngo)-total laryngectomy fistula between an early refeeding strategy (3rd or 4th postoperative day) and a late refeeding strategy (current standard of care: 7th postoperative day) in a low-risk fistula group defined according to the level of inflammatory cytokines in drainage fluids on the second postoperative day. Secondary objectives To compare an early versus a late refeeding strategy for patients at low risk of fistula defined according to the level of inflammatory cytokines in drainage fluids on the second postoperative day for: * length of hospital stay, * evolution of nutritional status, * time to postoperative radio-chemotherapy, if indicated postoperatively, * improvement in quality of life, * post-operative complications other than pharyngeal fistula. Evaluation of different strategies left to the investigator\'s choice (continuation of antibiotic therapy, increased delay before resumption of feeding, early resumption of surgery) in the group of patients at high risk of fistula, based on the determination of postoperative cytokines in drainage fluids. Primary endpoint: Pharyngo-cutaneous fistula occurring within 30 days post-operatively (yes/no). Number of subjects: 250 Inclusion criteria Major cancer patient justifying scheduled total laryngectomy or pharyngo-laryngectomy after multidisciplinary consultation. Holder of a social security plan. Non-inclusion criteria Pregnant and breast-feeding women Persons under curatorship, guardianship, safeguard of justice or deprived of liberty. Any medical condition deemed incompatible with the study by the investigator. Refusal to participate. Body mass index less than 18.5 kg/m2
CONDITIONS
Official Title
Rehabilitation Improved by Early Detection of Fisyulas Post (Pharyngo) -Total Laryngectomy by Cytokine Measurement on Drainage Fluid on the Second Post-Operative Day
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient with cancer requiring a total laryngectomy or pharyngolaryngectomy scheduled after multidisciplinary consultation.
- Holder of a social security scheme
You will not qualify if you...
- Pregnant and breastfeeding women
- Persons under curatorship, guardianship, legal protection or deprived of liberty
- Any medical condition deemed by the investigator to be incompatible with the study
- Refusal to participate
- Body mass index less than 18.5 kg/ m2
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France
Actively Recruiting
2
CHU de Grenoble
Grenoble, France
Not Yet Recruiting
3
CH Emile Roux
Le Puy-en-Velay, France
Not Yet Recruiting
4
HCL Hôpital Croix Rousse
Lyon, France
Not Yet Recruiting
5
CHU de Saint-Etienne
Saint-Etienne, France
Not Yet Recruiting
6
CH de Valence
Valence, France
Not Yet Recruiting
7
Institut Gustave Roussy
Villejuif, France
Not Yet Recruiting
Research Team
L
Lise Laclautre
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here